Page last updated: 2024-10-26

ethyl loflazepate and Seizures

ethyl loflazepate has been researched along with Seizures in 1 studies

ethyl loflazepate: structure given in first source

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research Excerpts

ExcerptRelevanceReference
"Ethyl loflazepate (Victan) is an original 1,4-benzodiazepine (BZD) being used as a potent, nonsedative, minor tranquillizer."1.27Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities. ( Bizière, K; Chambon, JP; Dantzer, R; Demarne, H; Hallot, A; Perio, A; Roncucci, R, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chambon, JP1
Perio, A1
Demarne, H1
Hallot, A1
Dantzer, R1
Roncucci, R1
Bizière, K1

Other Studies

1 other study available for ethyl loflazepate and Seizures

ArticleYear
Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities.
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:10

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Conflict, Ps

1985